TBOPP, a DOCK1 Inhibitor, Potentiates Cisplatin Efficacy in Breast Cancer by Regulating Twist-mediated EMT

Xin Chen(Jinan University)
Current Cancer Drug Targets
March 1, 2024
Cited by 2


Related Papers

Mitochondrial dysfunction: roles in skeletal muscle atrophy
|Journal of Translational Medicine|2023|275